MDXG
MiMedx Group, Inc.$3.89-0.04 (-1.02%)Prev Close$3.93·MCap$616.6M·P/E19.03·Vol874.4K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
2
$749.6K
◆
Net Activity
Net Seller
$749.6K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at MiMedx Group, Inc. (MDXG) has been exclusively selling, with 0 insider purchases totaling $0.00 and 2 insider sales totaling $749.6K. The most recent insider transaction was by Whitlow Ricci S (Chief Operating Officer), who sold $317.2K worth of shares on Feb 13, 2026. MiMedx Group, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $616.6M.
MDXG Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Whitlow Ricci S | Chief Operating Officer | Sell | 61,961 | $5.12 | $317.2K | 0 |
| Nov 10, 2025 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 58,300 | $7.42 | $432.3K | 236,982 |
| May 5, 2025 | Capper Joseph H | Chief Executive Officer | Buy | 200,000 | $6.34 | $1.27M | 529,530+61% |
| Mar 20, 2025 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 1,759 | $8.04 | $14.1K | 309,077 |
| Mar 14, 2025 | Hulse William Frank IV | General Counsel and CAO | Sell | 54,596 | $7.89 | $430.8K | 460,544 |
| Mar 14, 2025 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 4,106 | $7.89 | $32.4K | 310,836 |
| Mar 12, 2025 | Hulse William Frank IV | General Counsel and CAO | Sell | 81,446 | $7.80 | $635.3K | 494,774 |
| Mar 5, 2025 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 2,111 | $8.40 | $17.7K | 265,271 |
| Feb 18, 2025 | Whitlow Ricci S | Chief Operating Officer | Sell | 61,420 | $8.28 | $508.6K | 403,019 |
| Mar 15, 2024 | Hulse William Frank IV | General Counsel and CAO | Sell | 20,381 | $7.95 | $162.0K | 479,959 |
| Feb 21, 2024 | Whitlow Ricci S | Chief Operating Officer | Sell | 30,764 | $8.04 | $247.4K | 416,321 |
| Feb 16, 2024 | Whitlow Ricci S | Chief Operating Officer | Sell | 31,043 | $8.05 | $249.8K | 447,012 |
| Nov 22, 2023 | DOUG RICE | Chief Financial Officer | Buy | 5,000 | $7.16 | $35.8K | 102,200 |
| Jun 26, 2023 | Capper Joseph H | Chief Executive Officer | Buy | 100,000 | $6.40 | $640.4K | 100,000 |
| May 17, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 13,972 | $6.00 | $83.8K | 328,168 |
| May 12, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 5,976 | $5.93 | $35.4K | 656,435 |
| May 12, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 5,870 | $5.93 | $34.8K | 456,564 |
| May 12, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 1,595 | $5.93 | $9.5K | 184,219 |
| May 12, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 5,869 | $5.93 | $34.8K | 331,775 |
| May 9, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 51,756 | $5.34 | $276.5K | 337,644 |
| May 3, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 5,200 | $3.80 | $19.7K | 185,814 |
| Apr 27, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 6,094 | $3.74 | $22.8K | 662,411 |
| Apr 27, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 5,988 | $3.74 | $22.4K | 462,434 |
| Apr 27, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 1,628 | $3.74 | $6.1K | 191,014 |
| Apr 27, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 5,987 | $3.74 | $22.4K | 389,400 |
| Apr 13, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 6,100 | $3.31 | $20.2K | 668,505 |
| Apr 13, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 5,995 | $3.31 | $19.8K | 468,422 |
| Apr 13, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 1,632 | $3.31 | $5.4K | 192,642 |
| Apr 13, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 5,996 | $3.31 | $19.8K | 395,387 |
| Mar 9, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 12,056 | $4.24 | $51.2K | 534,150 |
| Mar 9, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 11,308 | $4.24 | $48.0K | 338,053 |
| Mar 9, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 3,396 | $4.24 | $14.4K | 141,244 |
| Mar 9, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 12,355 | $4.24 | $52.4K | 266,318 |
| Feb 24, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 19,000 | $4.50 | $85.4K | 546,206 |
| Feb 24, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 15,555 | $4.53 | $70.5K | 349,361 |
| Dec 27, 2022 | Carlson Peter M | Chief Financial Officer | Sell | 4,992 | $2.82 | $14.1K | 565,206 |
| Sep 14, 2022 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 27,329 | $3.44 | $94.1K | 287,002 |
| Aug 16, 2022 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 8,503 | $4.04 | $34.3K | 306,002 |
| Aug 11, 2022 | Kashyap Rohit | President, WC & Surgical | Sell | 12,343 | $4.21 | $51.9K | 430,072 |
| Aug 8, 2022 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 19,500 | $3.62 | $70.6K | 314,505 |
| Jun 30, 2022 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 14,600 | $3.47 | $50.7K | 334,005 |
| Jun 13, 2022 | WRIGHT TIMOTHY R | Chief Executive Officer | Sell | 112,000 | $3.75 | $420.0K | 1,711,324 |
| May 10, 2022 | Graves Mark | SVP & Chief Compliance Officer | Sell | 3,891 | $3.50 | $13.6K | 133,608 |
| May 10, 2022 | Phelan William Lawrence | Chief Accounting Officer | Sell | 5,750 | $3.81 | $21.9K | 144,640 |
| May 4, 2022 | Turner Scott M | SVP, Operations & Procurement | Sell | 5,260 | $4.00 | $21.0K | 226,643 |
| Mar 10, 2022 | Carlson Peter M | Chief Financial Officer | Sell | 10,743 | $4.86 | $52.2K | 382,698 |
| Mar 10, 2022 | Graves Mark | SVP & Chief Compliance Officer | Sell | 3,234 | $4.86 | $15.7K | 89,014 |
| Mar 10, 2022 | Hulse William Frank IV | General Counsel | Sell | 9,990 | $4.86 | $48.5K | 186,345 |
| Mar 10, 2022 | Kashyap Rohit | EVP & Chief Commercial Officer | Sell | 8,770 | $4.86 | $42.6K | 263,844 |
| Mar 10, 2022 | Phelan William Lawrence | Chief Accounting Officer | Sell | 3,268 | $4.86 | $15.9K | 97,360 |
Showing 1–50 of 59
1 / 2
MDXG Insider Buying Activity
The following table shows recent insider purchases of MiMedx Group, Inc. (MDXG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 5, 2025 | Capper Joseph H | Chief Executive Officer | Buy | 200,000 | $6.34 | $1.27M | 529,530+61% |
| Nov 22, 2023 | DOUG RICE | Chief Financial Officer | Buy | 5,000 | $7.16 | $35.8K | 102,200 |
| Jun 26, 2023 | Capper Joseph H | Chief Executive Officer | Buy | 100,000 | $6.40 | $640.4K | 100,000 |
MDXG Insider Selling Activity
The following table shows recent insider sales of MiMedx Group, Inc. (MDXG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Whitlow Ricci S | Chief Operating Officer | Sell | 61,961 | $5.12 | $317.2K | 0 |
| Nov 10, 2025 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 58,300 | $7.42 | $432.3K | 236,982 |
| Mar 20, 2025 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 1,759 | $8.04 | $14.1K | 309,077 |
| Mar 14, 2025 | Hulse William Frank IV | General Counsel and CAO | Sell | 54,596 | $7.89 | $430.8K | 460,544 |
| Mar 14, 2025 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 4,106 | $7.89 | $32.4K | 310,836 |
| Mar 12, 2025 | Hulse William Frank IV | General Counsel and CAO | Sell | 81,446 | $7.80 | $635.3K | 494,774 |
| Mar 5, 2025 | Maersk-Moller Kimberly | Chief Commercial Officer | Sell | 2,111 | $8.40 | $17.7K | 265,271 |
| Feb 18, 2025 | Whitlow Ricci S | Chief Operating Officer | Sell | 61,420 | $8.28 | $508.6K | 403,019 |
| Mar 15, 2024 | Hulse William Frank IV | General Counsel and CAO | Sell | 20,381 | $7.95 | $162.0K | 479,959 |
| Feb 21, 2024 | Whitlow Ricci S | Chief Operating Officer | Sell | 30,764 | $8.04 | $247.4K | 416,321 |
| Feb 16, 2024 | Whitlow Ricci S | Chief Operating Officer | Sell | 31,043 | $8.05 | $249.8K | 447,012 |
| May 17, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 13,972 | $6.00 | $83.8K | 328,168 |
| May 12, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 5,976 | $5.93 | $35.4K | 656,435 |
| May 12, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 5,870 | $5.93 | $34.8K | 456,564 |
| May 12, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 1,595 | $5.93 | $9.5K | 184,219 |
| May 12, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 5,869 | $5.93 | $34.8K | 331,775 |
| May 9, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 51,756 | $5.34 | $276.5K | 337,644 |
| May 3, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 5,200 | $3.80 | $19.7K | 185,814 |
| Apr 27, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 6,094 | $3.74 | $22.8K | 662,411 |
| Apr 27, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 5,988 | $3.74 | $22.4K | 462,434 |
| Apr 27, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 1,628 | $3.74 | $6.1K | 191,014 |
| Apr 27, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 5,987 | $3.74 | $22.4K | 389,400 |
| Apr 13, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 6,100 | $3.31 | $20.2K | 668,505 |
| Apr 13, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 5,995 | $3.31 | $19.8K | 468,422 |
| Apr 13, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 1,632 | $3.31 | $5.4K | 192,642 |
| Apr 13, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 5,996 | $3.31 | $19.8K | 395,387 |
| Mar 9, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 12,056 | $4.24 | $51.2K | 534,150 |
| Mar 9, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 11,308 | $4.24 | $48.0K | 338,053 |
| Mar 9, 2023 | Phelan William Lawrence | Chief Accounting Officer | Sell | 3,396 | $4.24 | $14.4K | 141,244 |
| Mar 9, 2023 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 12,355 | $4.24 | $52.4K | 266,318 |
| Feb 24, 2023 | Carlson Peter M | Chief Financial Officer | Sell | 19,000 | $4.50 | $85.4K | 546,206 |
| Feb 24, 2023 | Hulse William Frank IV | General Counsel and CAO | Sell | 15,555 | $4.53 | $70.5K | 349,361 |
| Dec 27, 2022 | Carlson Peter M | Chief Financial Officer | Sell | 4,992 | $2.82 | $14.1K | 565,206 |
| Sep 14, 2022 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 27,329 | $3.44 | $94.1K | 287,002 |
| Aug 16, 2022 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 8,503 | $4.04 | $34.3K | 306,002 |
| Aug 11, 2022 | Kashyap Rohit | President, WC & Surgical | Sell | 12,343 | $4.21 | $51.9K | 430,072 |
| Aug 8, 2022 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 19,500 | $3.62 | $70.6K | 314,505 |
| Jun 30, 2022 | Stein Robert Benjamin | President, Regenerative Med. | Sell | 14,600 | $3.47 | $50.7K | 334,005 |
| Jun 13, 2022 | WRIGHT TIMOTHY R | Chief Executive Officer | Sell | 112,000 | $3.75 | $420.0K | 1,711,324 |
| May 10, 2022 | Graves Mark | SVP & Chief Compliance Officer | Sell | 3,891 | $3.50 | $13.6K | 133,608 |
| May 10, 2022 | Phelan William Lawrence | Chief Accounting Officer | Sell | 5,750 | $3.81 | $21.9K | 144,640 |
| May 4, 2022 | Turner Scott M | SVP, Operations & Procurement | Sell | 5,260 | $4.00 | $21.0K | 226,643 |
| Mar 10, 2022 | Carlson Peter M | Chief Financial Officer | Sell | 10,743 | $4.86 | $52.2K | 382,698 |
| Mar 10, 2022 | Graves Mark | SVP & Chief Compliance Officer | Sell | 3,234 | $4.86 | $15.7K | 89,014 |
| Mar 10, 2022 | Hulse William Frank IV | General Counsel | Sell | 9,990 | $4.86 | $48.5K | 186,345 |
| Mar 10, 2022 | Kashyap Rohit | EVP & Chief Commercial Officer | Sell | 8,770 | $4.86 | $42.6K | 263,844 |
| Mar 10, 2022 | Phelan William Lawrence | Chief Accounting Officer | Sell | 3,268 | $4.86 | $15.9K | 97,360 |
MDXG Insiders
Similar Stocks to MDXG
MRNA
Moderna, Inc.
$199.23-1.59%
$96.65B
REGN
Regeneron Pharmaceuticals, Inc.
$806.67-1.52%
$81.41B
RVMD
Revolution Medicines, Inc.
$188.22+0.30%
$38.14B
ALNY
Alnylam Pharmaceuticals, Inc.
$224.68-1.14%
$31.02B
UTHR
United Therapeutics Corporation
$584.90+0.02%
$23.76B
INCY
Incyte Corporation
$116.28-0.53%
$23.64B
INSM
Insmed Incorporated
$93.83-1.30%
$20.89B
EXEL
Exelixis, Inc.
$64.76-0.79%
$16.23B